Marpai (NASDAQ:MRAI – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.65) earnings per share for the quarter, reports. Marpai had a negative net margin of 77.38% and a negative return on equity of 789.96%. The company had revenue of $8.71 million during the quarter.
Marpai Stock Performance
Shares of Marpai stock opened at $2.08 on Thursday. Marpai has a fifty-two week low of $0.33 and a fifty-two week high of $13.60. The company’s 50 day moving average price is $1.63 and its two-hundred day moving average price is $1.31.
Insider Buying and Selling at Marpai
In related news, CEO Damien Lamendola bought 1,100,000 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were purchased at an average price of $0.92 per share, for a total transaction of $1,012,000.00. Following the completion of the transaction, the chief executive officer now directly owns 1,951,306 shares of the company’s stock, valued at approximately $1,795,201.52. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have purchased 2,022,100 shares of company stock worth $2,524,632 over the last quarter. Corporate insiders own 61.30% of the company’s stock.
Hedge Funds Weigh In On Marpai
About Marpai
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.
Featured Stories
- Five stocks we like better than Marpai
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Cintas or UniFirst: Investors Win Either Way
- What is the Dogs of the Dow Strategy? Overview and Examples
- Best Bear Market Funds: Top 3 Investment Options to Consider
- What is the Dow Jones Industrial Average (DJIA)?
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.